CFTR gene therapy (Immunex)

N/A

Report date: 2023/10/26 16:59:57

Base Information

Drug NameCFTR gene therapy (Immunex)

Drug Alias NameCFTR基因疗法Adeno-associated virus based gene therapy (Immunex)

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of ActionChloride channel modulators

TargetsChloride channel

Therapy Area/IndicationsCystic Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAmgen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmgen Inc

Active IndicationsN/A

Inactive IndicationsCystic Fibrosis

ATC CodeN/A